Lundbeck

Lundbeck is a pioneering global pharmaceutical company dedicated to advancing brain health. With over 70 years of expertise in neuroscience, Lundbeck specializes in the research, development, manufacturing, and commercialization of innovative treatments for a spectrum of brain diseases. The company focuses on various conditions, including Alzheimer’s disease, Parkinson's disease, depression, schizophrenia, and migraine, aiming to enhance the quality of life for individuals affected by these disorders.

Lundbeck’s commitment to neuroscience extends beyond product development; the company actively engages in community initiatives and promotes diversity, equity, and inclusion. Through its "Progress in Mind" strategy, Lundbeck seeks to expand its impact in the field of brain health, continuously working to improve treatment options and accessibility. With a robust pipeline of products and a dedication to clinical trials and research, Lundbeck stands out as one of the few pharmaceutical entities fully concentrated on brain diseases, striving to empower patients and their families worldwide.